Figure 3.
Tumor targeting of known sites of disease. Images obtained 20 minutes, 3 hours, and 44 hours after the administration of 111In (5 mCi)/90Y (15 mCi/m2)–DOTA-biotin. Gamma camera wholebody scans of patient no. 1 (anterior views) obtained at 20 minutes, 3 hours, and 44 hours after infusion of 111In/90Y-DOTA-biotin. Arrows are showing radionuclide localization to known sites of tumor involvement.